Skip to main content
PMC home page
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
. 2008 Jun 28;17(6):791–798. doi: 10.1111/j.1939-1676.2003.tb02516.x

Effect of Early Enteral Nutrition on Intestinal Permeability, Intestinal Protein Loss, and Outcome in Dogs with Severe Parvoviral Enteritis

Albert J Mohr 1,✉, Andrew L Leisewitz 1, Linda S Jacobson 1, Jörg M Steiner 2, Craig G Ruaux 2, David A Williams 2
PMCID: PMC7166426  PMID: 14658714

Abstract

A randomized, controlled clinical trial investigated the effect of early enteral nutrition (EN) on intestinal permeability, intestinal protein loss, and outcome in parvoviral enteritis. Dogs were randomized into 2 groups: 15 dogs received no food until vomiting had ceased for 12 hours (mean 50 hours after admission; NPO group), and 15 dogs received early EN by nasoesophageal tube from 12 hours after admission (EEN group). All other treatments were identical. Intestinal permeability was assessed by 6‐hour urinary lactulose (L) and rhamnose (R) recoveries (%L, %R) and L/R recovery ratios. Intestinal protein loss was quantified by fecal α1‐proteinase inhibitor concentrations (α1‐PI). Median time to normalization of demeanor, appetite, vomiting, and diarrhea was 1 day shorter for the EEN group for each variable. Body weight increased insignificantly from admission in the NPO group (day 3: 2.5±2.8% day 6: 4.3±2.3% mean ± SE), whereas the EEN group exhibited significant weight gain (day 3: 8.1±2.7% day 6: 9.7 ± 2.1%). Mean urinary %L was increased, %R reduced, and L/R recovery ratios increased compared to reference values throughout the study for both groups. Percent lactulose recovery decreased in the EEN group (admission: 22.6±8.0% day 6: 17.9 ± 2.3%) and increased in the NPO group (admission: 11.0±2.6% day 6: 22.5 ± 4.6%, P= .035). Fecal α1‐PI was above reference values in both groups and declined progressively. No significant differences occurred for %R, L/R ratios, or α1‐PI between groups. Thirteen NPO dogs and all EEN dogs survived (P= .48). The EEN group showed earlier clinical improvement and significant weight gain. The significantly decreased %L in the EEN versus NPO group might reflect improved gut barrier function, which could limit bacterial or endotoxin translocation.

Keywords: Alpha1‐proteinase inhibitor, Canine, Gut barrier function, Lactulose, Rhamnose.

References

  • 1. Otto CM, Jackson CB, Rogell EJ, et al. Recombinant bactericidal/permeability‐increasing protein (rBPI21) for treatment of parvovirus enteritis: A randomized, double‐blinded, placebo‐controlled trial. J Vet Intern Med 2001;15:355–360. [PubMed] [Google Scholar]
  • 2. Macintire DK, Smith‐Carr S. Canine parvovirus. Part II. Clinical signs, diagnosis, and treatment. Comp Contin Educ Pract Vet 1997; 19: 291–302. [Google Scholar]
  • 3. Guilford WG, Strombeck DR. Gastrointestinal tract infections, parasites, and toxicoses In: Guilford WG, Center SA, Strombeck DR, Williams DA, Meyer DJ, eds. Strombeck's Small Animal Gastroenterology, 3rd ed. Philadelphia , PA : WB Saunders; 1996: 411–432. [Google Scholar]
  • 4. Dimmitt R. Clinical experience with cross‐protective anti‐endotoxin antiserum in dogs with parvoviral enteritis. Can Pract 1991;16:23–26. [Google Scholar]
  • 5. Mann FA, Boon GD, Wagner‐Mann CC, et al. Ionized and total magnesium concentrations in blood from dogs with naturally acquired parvoviral enteritis. J Am Vet Med Assoc 1998;212:1398–1401. [PubMed] [Google Scholar]
  • 6. Rewerts JM, McCaw DL, Cohn LA, et al. Recombinant human granulocyte colony‐stimulating factor for treatment of puppies with neutropenia secondary to canine parvovirus infection. J Am Vet Med Assoc 1998;213:991–992. [PubMed] [Google Scholar]
  • 7. Otto CM, Drobatz KJ, Soter C. Endotoxemia and tumor necrosis factor activity in dogs with naturally occurring parvoviral enteritis. J Vet Intern Med 1997;11:65–70. [DOI] [PubMed] [Google Scholar]
  • 8. Hoskins JD. Canine viral diseases In: Ettinger SJ, Feldman EC, eds. Textbook of Veterinary Internal Medicine, vol 1 Philadelphia , PA : WB Saunders; 2000: 420–422. [Google Scholar]
  • 9. Meunier PC, Cooper BJ, Appel MG, Slauson DO. Pathogenesis of canine parvovirus enteritis: The importance of viremia. Vet Pathol 1985;22:60–71. [DOI] [PubMed] [Google Scholar]
  • 10. Isogai E, Isogai H, Onuma M, et al. Escherichia coli associated endotoxemia in dogs with parvovirus infection. Jpn J Vet Sci 1989; 51:597–606. [DOI] [PubMed] [Google Scholar]
  • 11. Turk J, Miller M, Brown T, et al. Coliform septicemia and pulmonary disease associated with canine parvoviral enteritis: 88 cases (1987–1988). J Am Vet Med Assoc 1990;196:771–773. [PubMed] [Google Scholar]
  • 12. Windsor ACJ, Kanwar S, Li AGK, et al. Compared with parenteral nutrition, enteral feeding attenuates the acute phase response and improves disease severity in acute pancreatitis. Gut 1998;42:431–435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Carr CS, Ling KDE, Boulos P, Singer M. Randomised trial of safety and efficacy of immediate postoperative enteral feeding in patients undergoing gastrointestinal resection. Br Med J 1996;312:869–871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Gianotti L, Nelson JL, Alexander JW, et al. Post injury hyper‐metabolic response and magnitude of translocation: Prevention by early enteral nutrition. Nutrition 1994;10:225–231. [PubMed] [Google Scholar]
  • 15. Moore EE, Jones TN. Benefits of immediate jejunostomy feeding after major abdominal trauma–A prospective, randomized study. J Trauma 1986;26:874–880. [DOI] [PubMed] [Google Scholar]
  • 16. Moore EE, Moore FA. Immediate enteral nutrition following multisystem trauma: A decade perspective. J Am Coll Nutr 1991;10:633–648. [DOI] [PubMed] [Google Scholar]
  • 17. Moore FA, Feliciano DV, Andrassy RJ, et al. Early enteral feeding, compared with parenteral, reduces postoperative septic complications. Ann Surg 1992;216:172–183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Hadfield RJ, Sinclair DG, Houldsworth PE, Evans TW. Effects of enteral and parenteral nutrition on gut mucosal permeability in the critically ill. Am J Respir Crit Care Med 1995;152:1545–1548. [DOI] [PubMed] [Google Scholar]
  • 19. Lara TM, Jacobs DO. Effect of critical illness and nutritional support on mucosal mass and function. Clin Nutr 1998;17:99–105. [DOI] [PubMed] [Google Scholar]
  • 20. Heel KA, Kong SE, McCauley RD, et al. The effect of minimum luminal nutrition on mucosal cellularity and immunity of the gut. J Gastroenterol Hepatol 1998;13:1015–1019. [DOI] [PubMed] [Google Scholar]
  • 21. McCauley RD, Heel KA, Christiansen KJ, Hall JC. The effect of minimum luminal nutrition on bacterial translocation and atrophy of the jejunum during parenteral nutrition. J Gastroenterol Hepatol 1996;11:65–70. [DOI] [PubMed] [Google Scholar]
  • 22. Thatcher CD. Nutritional needs of critically ill patients. Comp Contin Educ Pract Vet 1996;18:1303–1312. [Google Scholar]
  • 23. Kompan L, Kremzar B, Gadzijev E, Prosek M. Effects of early enteral nutrition on intestinal permeability and the development of multiple organ failure after multiple injury. Intensive Care Med 1999; 25:157–161. [DOI] [PubMed] [Google Scholar]
  • 24. Chan DL, Freeman LM, Labato MA, Rush JE. Retrospective evaluation of partial parenteral nutrition in dogs and cats. J Vet Intern Med 2002;16:440–445. [DOI] [PubMed] [Google Scholar]
  • 25. Heyland DK, Cook DJ, Guyatt GH. Enteral nutrition in the critically ill patient: A critical review of the evidence. Intensive Care Med 1993;19:435–442. [DOI] [PubMed] [Google Scholar]
  • 26. Menzies IS, Laker MF, Pounder R, et al. Abnormal intestinal permeability to sugars in villous atrophy. Lancet 1979;2:1107–1109. [DOI] [PubMed] [Google Scholar]
  • 27. Bjarnason I, MacPherson A, Hollander D. Intestinal permeability: An overview. Gastroenterology 1995;108:1566–1581. [DOI] [PubMed] [Google Scholar]
  • 28. Travis S, Menzies IS. Intestinal permeability: Functional assessment and significance. Clin Sci 1992;82:471–488. [DOI] [PubMed] [Google Scholar]
  • 29. Maxton DG, Bjarnason I, Reynolds AP, et al. Lactulose, 51Cr‐labelled ethylenediaminetetra‐acetate, L‐rhamnose and polyethylene‐glycol 500 as probe markers for assessment in vivo of human intestinal permeability. Clin Sci 1986;71:71–80. [DOI] [PubMed] [Google Scholar]
  • 30. Hollander D, Ricketts D, Boyd CAR. Importance of ‘probe’ molecular geometry in determining intestinal permeability. Can J Gastroenterol 1988;2(Suppl A):35A–38A. [Google Scholar]
  • 31. Sorensen SH, Proud FJ, Adam A, et al. A novel HPLC method for the simultaneous quantification of monosaccharides and disaccha‐rides used in tests of intestinal function and permeability. Clin Chim Acta 1993;221:115–125. [DOI] [PubMed] [Google Scholar]
  • 32. Steiner JM, Williams DA, Moeller EM. Comparison of 8 hour 2‐sugar, 4‐sugar, and 5‐sugar gastrointestinal permeability and mucosal function tests in healthy dogs. 17th ACVIM Forum, Chicago, IL, 1999: 701.
  • 33. Melgarejo T, Williams DA, Asem EK. Enzyme‐linked immunosorbent assay for canine alpha 1‐protease inhibitor. Am J Vet Res 1998; 59: 127–130 (erratum Am J Vet Res 1998 524). [PubMed] [Google Scholar]
  • 34. Hall EJ, Batt RM. Differential sugar absorption for the assessment of canine intestinal permeability: The cellobiose/mannitol test in gluten‐sensitive enteropathy of Irish setters. Res Vet Sci 1991; 51:83–87. [DOI] [PubMed] [Google Scholar]
  • 35. Zeger SL, Liang K‐Y, Albert PS. Models for longitudinal data: A generalized estimating equation approach. Biometrics 1988;44:1049–1060. [PubMed] [Google Scholar]
  • 36. Welsh FKS, Farmery SM, MacLennan K, et al. Gut barrier function in malnourished patients. Gut 1998;42:396–401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Hollander D. The intestinal permeability barrier. A hypothesis as to its regulation and involvement in Crohn's disease. Scand J Gastroenterol 1992; 27: 721–726. [DOI] [PubMed] [Google Scholar]
  • 38. Bijlsma PB, Peeters RA, Groot JA, et al. Differential in vivo and in vitro intestinal permeability to lactulose and mannitol in animals and humans: A hypothesis. Gastroenterology 1995;108:687–696. [DOI] [PubMed] [Google Scholar]
  • 39. Schmitz H, Fromm M, Bentzel CJ, et al. Tumor necrosis factor‐alpha (TNF‐alpha) regulates the epithelial barrier in the human intestinal cell line HT‐29/B6. J Cell Sci 1999;112:137–146. [DOI] [PubMed] [Google Scholar]
  • 40. Cobden I, Rothwell J, Axon ATR. Passive permeability in experimental intestinal damage in rats. Clin Sci 1981;60:115–118. [DOI] [PubMed] [Google Scholar]
  • 41. Quigg J, Brydon G, Ferguson A, Simpson J. Evaluation of canine small intestinal permeability using the lactulose/rhamnose urinary excretion test. Res Vet Sci 1993;55:326–332. [DOI] [PubMed] [Google Scholar]
  • 42. Deitch EA, Rutan, R , Waymack JP. Trauma, shock, and gut translocation. New Horizons 1996;4:289–299. [PubMed] [Google Scholar]
  • 43. Cheung LY, Stephenson LW, Moody FG, et al. Direct effects of endotoxin on canine gastric mucosal permeability and morphology. J Surg Res 1975;18:417–425. [DOI] [PubMed] [Google Scholar]
  • 44. Turk J, Fales W, Miller M, et al. Enteric Clostridium perfringens infection associated with parvoviral enteritis in dogs: 74 cases (1987–1990). J Am Vet Med Assoc 1992;200:991–994. [PubMed] [Google Scholar]
  • 45. Rutgers HC, Batt RM, Proud FJ, et al. Intestinal permeability and function in dogs with small intestinal bacterial overgrowth. J Small Anim Pract 1996;37:428–434. [DOI] [PubMed] [Google Scholar]
  • 46. Bijlsma PB, Fihn BM, Sjoqvist A, et al. Water absorption enhances the uptake of mannitol and decreases Cr‐EDTA/mannitol permeability ratios in cat small intestine in situ. Scand J Gastroenterol 2002;37:799–806. [PubMed] [Google Scholar]
  • 47. Montejo JC. Enteral nutrition‐related gastrointestinal complications in critically ill patients: A multicenter study. Crit Care Med 1999;27:1447–1453. [DOI] [PubMed] [Google Scholar]
  • 48. Marks SL, Cook AK, Reader R, et al. Effects of glutamine supplementation of an amino acid–based purified diet on intestinal mucosal integrity in cats with methotrexate‐induced enteritis. Am J Vet Res 1999;60:755–763. [PubMed] [Google Scholar]
  • 49. Heyman M, Corthier G, Petit A, et al. Intestinal absorption of macromolecules during viral enteritis: An experimental study on rotavirus‐infected conventional and germ‐free mice. Pediatr Res 1987; 22:72–78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Mosenthal AC, Xu D, Deitch EA. Elemental and intravenous total parenteral nutrition diet‐induced gut barrier failure is intestinal site specific and can be prevented by feeding nonfermentable fiber. Crit Care Med 2002;30:396–402. [DOI] [PubMed] [Google Scholar]
  • 51. Spaeth G, Specian RD, Berg RD, Deitch EA. Bulk prevents bacterial translocation induced by the oral administration of total parenteral nutrition solution. J Parenter Enteral Nutr 1990;14:442–447. [DOI] [PubMed] [Google Scholar]
  • 52. Beale RJ, Bryg DJ, Bihari DJ. Immunonutrition in the critically ill: A systematic review of clinical outcome. Crit Care Med 1999;27:2799–2805. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Veterinary Internal Medicine are provided here courtesy of Wiley

RESOURCES